Clinical Trial Update: UNITO-001- Study in HRR/PDL1 Positive MPM/NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial update for UNITO-001 in HRR/PD-L1 positive malignant pleural mesothelioma and non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Mesothelioma

Drugs mentioned

• UNITO-001

Snippet

Sponsor: University of Turin, Italy | Conditions: Lung Cancer, Mesothelioma | Phase 2 | Status: UNKNOWN